Altered expression, intracellular distribution and activity of lymphocyte calpain II in Duchenne muscular dystrophy

Clinica Chimica Acta

Volumn 373, Issue 1-2, 2006, Pages 82-87

  Shanmuga Sundaram, J ^a   Mohana Rao, V ^a   Meena, A K ^b   Anandaraj, M P J S ^a  

^a OSMANIA UNIVERSITY   (India)

^b NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Activation; Calpain II; DMD; DMD lymphocytes; Expression

Indexed keywords

CALCIUM; CALPAIN II; DYSTROPHIN; PROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE DELETION; HUMAN; HUMAN CELL; LYMPHOCYTE; MEMBRANE DAMAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION;

CALPAIN; CELL MEMBRANE; CYTOSOL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LYMPHOCYTES; MUSCULAR DYSTROPHY, DUCHENNE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCELLULAR FRACTIONS;

EID: 33748199182     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.05.004     Document Type: Article

References (52)

1. Walton J.N., and Gardner M.D. In: Walton J. (Ed). Disorders of voluntary muscle (1981), Churchill Livingstone, Edinburgh
2. Emery A.E.H., and Burt D. Intracellular calcium and pathogenesis and antenatal diagnosis of DMD. Br Med J 280 (1980) 355-357
3. Franco Jr. A., and Lansman J.B. Calcium entry through stretch-inactivated ion channels in mdx myotubes. Nature 344 (1990) 670-673
4. Moens P., Beatsen P.H., and Marechal G. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J Muscle Res Cell Motil 14 (1993) 446-451
5. Bodensteiner J.B., and Engel A.G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 28 (1978) 439-446
6. Yarom R., Meyer S., More R., Liebergalt M., and Elder A. Platelet abnormalities in muscular dystrophy. Thromb Haemost 49 (1983) 168-172
7. Lechi C., Sinigaglia D., Guzzo P., Bonadonna G., and Zatti M. Platelet intracellular calcium in patients in with Duchenne muscular dystrophy. Clin Chim Acta 177 (1988) 119-121
8. Dice C.A., Goodman D.B.P., Lake W.C., Hodson A., and Rasmussen H. Enhanced sensitivity to calcium in Duchenne muscular dystrophy. Biochem Biophys Res Commun 79 (1977) 1286-1292
9. Nicholson G.A., and Sugars J. Decreased A23187 induced chemiluminescence in Duchenne muscular dystrophy granulocytes. J Neurosci 56 (1982) 11-16
10. Fingerman E., and Campisi J. Decreased A23187 induced chemiluminescence in Duchenne muscular dystrophy: effects on cellular and viral growth. Proc Natl Acad Sci U S A 81 (1984) 7617-7621
11. Chelly J., Kaplan J.C., Maire P., Gautron S., and Kahn A. Transcription of the Dystrophin gene in human muscle and non-muscle tissues. Nature 333 (1988) 858-860
12. Nishio H., Takeshima Y., Naoko N., et al. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known peomoter. J Clin Invest 94 (1994) 1037-1042
13. Nakajima T., Fukiage C., Azuma M., Ma H., and Shearer T.R. Different expression patterns of ubiquitous calpains and Capn# splice variants in monkey ocular tissues. Biochim Biophys Acta 1519 (2001) 55-64
14. De Tullio R., Stifanese R., Salamino F., Pontremoli S., and Melloni E. Characterization of new p94-like calpain form in human lymphocytes. Biochem J 375 (2003) 689-696
15. Suzuki K., Hata S., Kawabata Y., and Sorimachi H. Structure, activation, and biology of calpain. Diabetes 53 (2004) S12-S18
16. Goll D.E., Thompson V.F., Li H., and Cong J. The role of the calpain system in neuromuscular disease. Role of proteases in the pathophysiology of neurodegenerative diseases (2001), Kluwer academic/Plenum publishers, Newyork
17. Croall D.E., and Demartino G.N. Calcium-activated neutral protease (Calpain) system: structure, function and regulation. Physiol Rev 71 (1991) 813-847
18. Sato K., and Kawashima S. Calpain function in the modulation of signal transduction molecules. Biol Chem 382 (2001) 743-751
19. Huang Y., and Wang K.K.K. The calpain family and human disease. Trends Mol Med 7 (2001) 355-362
20. Moses L., Shailaja B., and Anandaraj M.P.J.S. Calcium activated neutral protease in blood cells from patients and carriers of Duchenne muscular dystrophy. Ind J Med Res 92 (1990) 5-12
21. Jagadeesh G., Shailaja B., Moses L., Kusuma Kumari C., Anjaneyulu A., and Anandaraj M.P.J.S. Importance of monitoring calcium and calcium related properties in carrier detection for Duchenne muscular dystrophy. Ind J Med Res 99 (1994) 283-288
22. Hussain T., Magath H., Sundaram C., and Anandaraj M.P.J.S. Expression of the gene for large subunit of m-calpain is elevated in skeletal muscle from Duchenne muscular dystrophy patients. J Genet 79 (2000) 77-80
23. Kalofoutis A., Nicolaidou-Politis V., and Bouloukas A. Significance of lymphocyte fatty acid changes in chronic renal failure. Nephron 73 (1996) 704-706
24. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
25. Siebert P.D., and Chenchik A. Modified acid guanidium thiocynate-phenol-chloroform RNA extraction method which greatly reduces DNA contamination. Nucleic Acid Res 21 (1993) 2019-2020
26. Tso J.Y., Sun X., Kao T., Reece K.S., and Wu R. Isolation and characterization of rat and human glyceraldehydes-3-phosphate dehydrogenase cDNA:genomic complexity and molecular evolution of the gene. Nucleic Acid Res 13 (1985) 2485-2502
27. Zong W.X., Hatzivassiliou G., Lindsten T., Yu Q.C., Yuan J., and Thompson C.B. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol 162 (2003) 59-69
28. Shastri R., and Anandaraj M.P.J.S. A low calcium requiring calcium activated neutral proteinase from human placenta. Biochem Biophys Acta 873 (1986) 260-266
29. Tijssen P. Laboratory techniques in biochemistry and molecular biology. In: Burdon R.H., and Van Knippenberg P.H. (Eds). Practice and Theory of Enzyme Immuno Assays vol. 15 (1985), Elsevier, Amsterdam 105-113
30. Hussain T., Narayan Kumar D.V., Sundaram C., Mohandas S., and Anandaraj M.P.J.S. Quantitative ELISA for platelet m-calpain: a phenotypic index for detection of carriers of Duchenne muscular dystrophy. Clin Chim Acta 269 (1998) 13-20
31. Croall D.E., Moffett K., and Hatch H. Casein zymography of calpains using a 4-(2-hydroxyethy)-1-piperazineethanesulfonic acid-imidazole buffer. Anal Biochem 304 (2002) 129-132
32. 2+ requirement of calpain activation. Biochem Biophys Res Commun 323 (2004) 1131-1133
33. 2+-dependent thiol protease) with its endogenous inhibitor calpastatin in myoblasts. J Cell Biochem 74 (1999) 522-531
34. De Tullio R., Passalacqua M., Averna M., Salamino F., Melloni E., and Pontremoli S. Changes in intracellular localization of calpastatin during calpain activation. Biochem J 343 (1999) 467-472
35. Shailaja B., Jagadeesh G., Hussain T., and Anandaraj M.P.J.S. Quantitation of endogenous inhibitor of milli CANP in Duchenne muscular dystrophy platelets and lymphocytes: its implication in regulation. Ind J Clin Biochem 11 (1996) 2
36. Deshpande R.V., Goust J.M., Chakrabarti A.K., Barbosa E., Hogan E.L., and Banik N.L. Calpain expression in lymphoid cells. Increased mRNA and protein levels after cell activation. J Biol Chem 270 (1995) 2497-2505
37. Suzuki K., and Sorimachi H. A novel aspect of calpain activation. FEBS Lett. 433 (1998) 1-4
38. Kinbara K., Ishiura S., Tomioka S., et al. Purification of native p94, a muscle specific calpain, and characterization of its autolysis. Biochem J 335 (1998) 589-596
39. Ono Y., Sorimachi H., and Suzuki K. Structure and physiology of calpain, an enigmatic protease. Biochem Biophys Res Commun 245 (1998) 289-294
40. Liu Z.Q., Kunimatsu M., Yang J.P., Ozaki Y., Sasaki M., and Okamoto T. Proteolytic processing of nuclear factor κB by calpain in vitro. FEBS Lett 385 (1996) 109-113
41. Han Y., Weinman S., Boldogh I., Walker R.K., and Brasier A.R. Tumor necrosis factor-α-inducible IκBα proteolysis mediated by cytosolic m-calpain: a mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-κb activation. J Biol Chem 274 (1999) 787-794
42. Romero P.J. Possible new modulators of the calcium pump of human erythrocytes. Acta Cient Venez 44 (1993) 74-80
43. Lavanya M., and Anandaraj M.P.J.S. Membrane calcium, magnesium ATPase activation by calcium activated neutral protease in conditions were there is elevated intracellular calcium. J Ind Inst Sci Bangalore 69 (1989) 97-105
44. Jagadeesh G., Lavanya M., Anandaraj M.P.J.S., and Anjaneyulu A. Altered protein kinase C and protein kinase A activities in erythrocyte membrane, platelets and lymphocytes of Duchenne muscular dystrophy (DMD) patients. Clin Chim Acta 193 (1990) 79-84
45. Morford L.A., Foreest K., Logan B., et al. Calpain II colocalizes with detergent-insoluble rafts on human and jurkat-T-cells. Biochem Biophys Res Commun 295 (2002) 540-546
46. Hood J.L., Logan B.B., Sinai A.P., Brooks W.H., and Roszman T.L. Association of the calpain/calpastatin network with subcellular organelles. Biochem Biophys Res Commun 310 (2003) 1200-1212
47. Sensi A., Venturoli A., Traniello S., et al. Impaired HLA capping capacity of peripheral blood lymphocytes in Duchenne muscular dystrophy. J Med Genet 21 (1984) 182-185
48. Goldsmith B.M., and Hanns-Dieter G. Systemic membrane defect and the inhibition of lymphocyte capping in Duchenne muscular dystrophy. Clin Chim Acta 164 (1987) 33-46
49. Hubner C., Kohlschutter A., and Gartner J. Membrane fluidity of non-muscle cells in Duchenne muscular dystrophy: effect on lymphocyte membranes of incubation in patient and control sera. Pediatric Res 22 (1987) 488-492
50. Chelly J., Kaplan J.C., Maire P., Gautron S., and Kahn A. Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333 (1988) 858-860
51. Nishio H., Takeshima Y., Naoko N., et al. Identification of a novel first exon in the human Dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest 94 (1994) 1037-1042
52. Spencer M.J., and Tidball J.G. Do immune cells promote the pathology of dystrophin-deficient myopathies. Neuromuscul Disord 11 (2001) 556-564